3Susan J, Karin T, Kim H. Comparing two met hods of topicalanes the siaused before intravenous can nulation in pediatricp at ients. Journal of Pediatric Health Care ,2000,14:68.
4Malek AM, Goss GG,Jiang L, et al. Mannitol at clinical concentraions ac- tivates multiple singaling pathways and induces apoptosis in endothelial Cells. Stroke, 1998,29 : 2631-2640.
5张爱知,马伴吟主编.实用药物手册.第1版.上海:上海科学技术出版社,2002.96.
6Infusion Nurses Society Standards Committee. Infusion nursing standards of practice. Journal of Infusion Nursing,2006,29 : 39.
7Passalacqua G, Antonino M, Silvia P, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY Project: Evaluation of A novel SLIT formulation during a Year). Pediatr Allergy Immunol. 2007,18:58-62.
8Sawyer RT, Gergen P. The future of immunotherapy. Report of a National Institute of Allergy and Infectious Diseases ( NIAID), DiviSion of AUer- gy, Immunology and Transplantation (DAIT) Workshoip. J Allergy, 2006,61:1159-1161.
